Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EHC - Encompass Health Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$150.20
DETAILS
HIGH:
$155.00
LOW:
$144.00
MEDIAN:
$150.00
CONSENSUS:
$150.20
UPSIDE:
17.46%
Stock News
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health Expands Rehab Footprint With New Maine Hospital
EHC opens a 50-bed Maine rehab hospital, expanding its footprint as strong discharge growth and planned openings support capacity expansion.
Encompass Health Rehabilitation Hospital of Bangor now open in Maine
BIRMINGHAM, Ala. and BANGOR, Maine, Oct. 6, 2026 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Bangor in Bangor, Maine.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health announces date of 2026 third-quarter earnings call
BIRMINGHAM, Ala., Oct. 1, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept.
Encompass Health Adds New Capacity With First Small-Format Hospital
EHC is expanding near Houston with its first small-format rehab hospital and a 60-bed replacement facility in The Woodlands.
Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital
BIRMINGHAM, Ala., and CONROE, Texas, Sept.
Encompass Health (EHC) Upgraded to Buy: Here's Why
Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Encompass Health (EHC) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Encompass Health (EHC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania
BIRMINGHAM, Ala. and EAGLEVILLE, Pa.
Engineers Gate Manager LP Sells 16,849 Shares of Encompass Health Corporation $EHC
Engineers Gate Manager LP lowered its holdings in Encompass Health Corporation (NYSE: EHC) by 38.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,953 shares of the company's stock after selling 16,849 shares during the quarter. Engineers Gate Manager
Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?
76,400 Shares in Encompass Health Corporation $EHC Purchased by Canada Pension Plan Investment Board
Canada Pension Plan Investment Board acquired a new position in Encompass Health Corporation (NYSE: EHC) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 76,400 shares of the company's stock, valued at approximately $7,723,000. Canada Pension Plan Investment Board owned
Deutsche Bank AG Invests $1.28 Million in Encompass Health Corporation $EHC
Deutsche Bank AG purchased a new stake in Encompass Health Corporation (NYSE: EHC) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,716 shares of the company's stock, valued at approximately $1,285,000. Several other hedge funds and other institutional investors have
Encompass Health Is Healthy Enough To Justify A Bullish View
Encompass Health Corporation is the largest U.S. inpatient rehabilitation hospital operator, showing robust top- and bottom-line growth with industry-leading balance sheet strength. EHC is executing a disciplined expansion strategy, targeting 6–10 new hospitals and 80–120 bed additions annually, supported by favorable US demographic trends. Despite trading at a premium to peers, EHC's valuation remains attractive given its growth, profitability, and declining net leverage ratio.
Ancora Advisors LLC Buys New Stake in Encompass Health Corporation $EHC
Ancora Advisors LLC purchased a new stake in Encompass Health Corporation (NYSE: EHC) during the second quarter, according to its most recent filing with the SEC. The fund purchased 105,258 shares of the company's stock, valued at approximately $10,639,000. Ancora Advisors LLC owned about 0.11% of Encompass Health as of its most recent
808,034 Shares in Encompass Health Corporation $EHC Purchased by Bank of New York Mellon Corp
Bank of New York Mellon Corp purchased a new stake in shares of Encompass Health Corporation (NYSE: EHC) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 808,034 shares of the company's stock, valued at approximately $81,676,000. Bank of New York Mellon Corp
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway
Encompass Health's capacity expansion, new facilities and North Carolina pipeline could fuel 6-8% multi-year discharge growth.
Price Targets
Raymond James Assumes Encompass Health Corp (EHC) at Strong Buy
$150.00
(was $123.47)
Andrew Cooper
·
Raymond James
Encompass Health price target raised to $150 from $140 at Truist
$150.00
(was $125.42)
David MacDonald
·
Truist Financial
Encompass Health price target raised to $155 from $150 at UBS
$155.00
(was $125.45)
UBS
Encompass Health price target raised to $144 from $140 at Barclays
$144.00
(was $110.90)
Barclays
Encompass Health Corp (EHC) PT Raised to $152 at Leerink
$152.00
(was $104.45)
Whit Mayo
·
Leerink Partners
Encompass Health price target lowered to $140 from $153 at Barclays
$140.00
(was $106.64)
Barclays
Encompass Health price target raised to $153 from $150 at Barclays
$153.00
(was $99.56)
Barclays
Encompass Health price target raised to $150 from $141 at Barclays
$150.00
(was $125.63)
Andrew Mok
·
Barclays
Encompass Health price target raised to $150 from $140 at UBS
$150.00
(was $124.52)
UBS
Encompass Health price target raised to $140 from $135 at Truist
$140.00
(was $119.30)
David MacDonald
·
Truist Financial
Encompass Health price target raised to $125 from $110 at RBC Capital
$125.00
(was $115.32)
RBC Capital
Encompass Health price target raised to $105 from $95 at RBC Capital
$105.00
(was $96.75)
Ben Hendrix
·
RBC Capital
Encompass Health price target raised to $110 from $100 at UBS
$110.00
(was $95.26)
AJ Rice
·
UBS
Encompass Health Corp (EHC) PT Raised to $95 at RBC Capital
$95.00
(was $85.86)
Frank Morgan
·
RBC Capital
Encompass Health Corp (EHC) PT Raised to $95 at Mizuho
$95.00
(was $82.80)
Ann Hynes
·
Mizuho Securities
Encompass Health Corp (EHC) PT Raised to $101 at Barclays
$101.00
(was $81.79)
Andrew Mok
·
Barclays
RBC Capital Maintains Outperform on Encompass Health, Lowers Price Target to $85
$85.00
(was $68.24)
RBC Capital
Raymond James Maintains Strong Buy on Encompass Health, Raises Price Target to $85
$85.00
(was $68.83)
Raymond James
Credit Suisse Maintains Outperform on Encompass Health, Raises Price Target to $83
$83.00
(was $68.46)
Credit Suisse
Encompass Health Corp (EHC) PT Raised to $100 at Stephens
$100.00
(was $84.62)
Scott Fidel
·
Stephens